Literature DB >> 2394723

Purification of a reconstitutively active K+/H+ antiporter from rat liver mitochondria.

X Q Li1, M G Hegazy, F Mahdi, P Jezek, R D Lane, K D Garlid.   

Abstract

We describe purification of three different states of the 82-kDa K+/H+ antiporter from rat liver mitochondria. The denatured 82-kDa protein, identified by its selective labeling with [14C]dicyclohexylcarbodiimide (DCCD), was purified by preparative two-dimensional gel electrophoresis. This purified product was used to raise and immunopurify monospecific polyclonal antibodies. Western blot analysis showed that the [14C] DCCD-labeled 82-kDa protein is not a DCCD-crosslinked product. The native, [14C]DCCD-labeled, 82-kDa protein was purified by (NH4)2SO4 fractionation and column chromatography, using 14C labeling and gel electrophoresis to track the protein. The native, non-DCCD-labeled 82-kDa protein was purified by similar procedures, using immunopurified antibodies to track the protein. DCCD binding had no effect on chromatographic behavior of the antiporter protein. This protocol resulted in purification of the 82-kDa protein to apparent homogeneity. The purified, native 82-kDa protein was reconstituted into proteoliposomes and assayed for K+ transport with the new fluorescent probe, PBFI. K+ transport was electroneutral and was inhibited by DCCD, Mg2+, and timolol. The turnover number for K+ transport was about 1000 s-1, very similar to the value previously estimated in intact mitochondria.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2394723

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Mitochondrial matrix K+ flux independent of large-conductance Ca2+-activated K+ channel opening.

Authors:  Mohammed Aldakkak; David F Stowe; Qunli Cheng; Wai-Meng Kwok; Amadou K S Camara
Journal:  Am J Physiol Cell Physiol       Date:  2010-01-06       Impact factor: 4.249

2.  Advances in the purification of the mitochondrial Ca2+ uniporter using the labeled inhibitor 103Ru360.

Authors:  C Zazueta; G Zafra; G Vera; C Sánchez; E Chávez
Journal:  J Bioenerg Biomembr       Date:  1998-10       Impact factor: 2.945

3.  Mitochondrial ROMK channel is a molecular component of mitoK(ATP).

Authors:  D Brian Foster; Alice S Ho; Jasma Rucker; Anders O Garlid; Ling Chen; Agnieszka Sidor; Keith D Garlid; Brian O'Rourke
Journal:  Circ Res       Date:  2012-07-17       Impact factor: 17.367

Review 4.  Mitochondrial cation transport: a progress report.

Authors:  K D Garlid
Journal:  J Bioenerg Biomembr       Date:  1994-10       Impact factor: 2.945

Review 5.  Na+/H+ antiporters, molecular devices that couple the Na+ and H+ circulation in cells.

Authors:  E Padan; S Schuldiner
Journal:  J Bioenerg Biomembr       Date:  1993-12       Impact factor: 2.945

6.  Evidence for three different electrophoretic pathways in yeast mitochondria: ion specificity and inhibitor sensitivity.

Authors:  S Manon; M Guérin
Journal:  J Bioenerg Biomembr       Date:  1993-12       Impact factor: 2.945

7.  Investigations of the inhibitory effect of propranolol, chlorpromazine, quinine, and dicyclohexylcarbodiimide on the swelling of yeast mitochondria in potassium acetate. Evidences for indirect effects mediated by the lipid phase.

Authors:  X Roucou; S Manon; M Guérin
Journal:  J Bioenerg Biomembr       Date:  1995-06       Impact factor: 2.945

Review 8.  Cation transport systems in mitochondria: Na+ and K+ uniports and exchangers.

Authors:  G P Brierley; K Baysal; D W Jung
Journal:  J Bioenerg Biomembr       Date:  1994-10       Impact factor: 2.945

9.  Characterization of the sodium/hydrogen exchanger NHA2.

Authors:  Daniel G Fuster; Jianning Zhang; Mingjun Shi; I Alexandru Bobulescu; Stefan Andersson; Orson W Moe
Journal:  J Am Soc Nephrol       Date:  2008-05-28       Impact factor: 10.121

10.  Modeling mitochondrial bioenergetics with integrated volume dynamics.

Authors:  Jason N Bazil; Gregery T Buzzard; Ann E Rundell
Journal:  PLoS Comput Biol       Date:  2010-01-01       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.